SUMMARY
were also enhanced when halothane was present (0.51 ±0.03g of the fibres to be oxygenated and exposed to the drugs introduced to the bath. The purpose of the present study was to develop a mammalian (small rodent) model system in which halothane-induced contractures and the interaction between suxamethonium and halothane could be conveniently examined in vitro. In this study agents known to antagonize phospholipase A s (PLAj) activity were used to determine whether PLAj activity could be involved in halothane-induced contractures of the rat diaphragm. Dantrolene, the drug of choice for epidoses of MH, was used, as dantrolene has been shown previously to block halothane-induced contractures in muscle strips from other species. Finally, the effects of tubocurarine were examined on the synergistic induction of contractures by halothane and suxamethonium (Gronert, 1980) .
MATERIALS AND METHODS
Male Sprague-Dawley rats (200-400 g) were decapitated and the diaphragm was removed. Muscle strips (about 4 x 8 x 0.5 mm) were prepared by cutting the diaphragm parallel to the direction of the fibres from the rib section to the central tendon. Dissection was undertaken at 25 °C in Krebs solution composed of (mmol litre-1 ): NaCl 118, KC13.4, MgSO 4 0.8, KH 2 PO 4 1.2, glucose 11.1, NaHCO, 25.0 and CaC^ 2.5, and pH adjusted to 7.4. Usually, eight to 12 muscle strips could be prepared from a single diaphragm. Preparations were mounted in a tissue bath containing Krebs solution at 37 °C and bubbled with oxygen-carbon dioxide (95:5). The rib section of each strip was tied to a fixed position stimulating electrode and the central tendon connected to a force transducer. The muscle strips were adjusted to an initial resting tension of 1 g and directly stimulated at 0.2 Hz with supramaximal voltage pulses of 2 ms duration. Only preparations maintaining a stable resting tension for 30 min were used subsequently. Following the 30-min equilibration period, 1 % halothane was added to the gas phase. The time of exposure to halothane alone was 5 min. Suxamethonium was then added to the bath and the maximum contracture within 5 min to both agents recorded. In some experiments suxamethonium was added to the bath 5 min before halothane. When interaction studies were carried out with suxamethonium and halothane, those strips exhibiting a contracture greater than 0.5 g to the first agent added (except to 3% halothane) were not used further in the study. This resulted in rejection of about 10% of the total number of strips tested. These strips were eliminated because, on occasions, the resting tension of the preparation would not recover from the effect of the administration of the first drug before it was time to add the second agent. The results are expressed in terms of numbers of rats used. For each rat the average BRITISH JOURNAL OF ANAESTHESIA response of one to 12 strips was treated as a single value. When used, tubocurarine, spermine, indomethacin, quinacrine or dantrolene was added to the bath 2 min before suxamethonium or halothane. Krebs solution was the solvent for all drugs in the study, as solvents such as ethanol potentiate contractures induced by halothane (unpublished observations). The pH was adjusted to 7.4 for each solution of drug. Solutions of dantrolene and indomethacin were sonicated before use. Indomethacin and tubocurarine were not completely soluble at 1 and 50 mmol litre" 1 , respectively. The halothane concentration in the gas phase was confirmed by gas chromatography, using an OV-101 (3%) Chrom-W-HP 100-120 mesh (Perkin-Elmer) column.
Indomethacin, spermine, quinacrine, suxamethonium and tubocurarine were purchased from Sigma Chemical Co. (St Louis, MO). Caffeine was obtained from Eastman (Rochester, NY) and halothane from Ay erst (New York, NY). Dantrolene sodium was a gift of Norwich Pharmaceutical Co. (Norwich, NY).
The unpaired data in tables I and IV were each analysed using a one-way analysis of variance followed by Duncan's multiple range test. Significance was tested at the P < 0.05 level. The data in tables II and III were analysed using two-sided paired t tests.
RESULTS
The typical responses of the strips of rat diaphragm muscle to halothane and suxamethonium alone, or in combination, are demonstrated in figure 1. Preparations exhibited significantly greater contractures to either halothane or suxamethonium if the other agent was also present in the bath, than to either agent alone. The diaphragms from some rats exhibited greater contractures to 1 % halothane or suxamethonium 50 mmol litre" 1 when administered alone than did those from other rats (unpublished observations). Some young rats (about 6 weeks of age) exhibited contractures to halothane that exceeded 1.2 g. Currently, we believe the response to these agents may vary with season and age.
Halothane 1 % elicited relatively small contractures from the rat diaphragm preparation (table  I) . The size of the contractures was significantly increased when the concentration of halothane was increased to 3% (table I) . Contractures induced by 1 % halothane in preparations preexposed to suxamethonium became increasingly greater in magnitude as the suxamethonium concentration was increased in the range of 1-50 mmol litre" 1 (table I) . There was no response to suxamethonium at the concentrations of 1 or 10 mmol litre" 1 in the absence or presence of 1 % halothane. Contractures induced by suxamethonium 50 mmol litre" 1 were not significantly different from those induced by 1% halothane. Suxamethonium 50 mmol litres-induced contractures were increased significantly when preparations were preincubated with 1 % halothane (table I) . Contractures induced by suxamethonium 50 mmol litre" 1 in the presence of halothane did not increase significantly when the halothane concentration was increased to 3 %. In contrast, halothane-induced contractures in the presence of suxamethonium 50 mmol litre" 1 were greater at a halothane concentration of 3 % than at 1 % (table I) .
The effects of various antagonists were examined with 1 % halothane and suxamethonium 50 mmol litre"
1 . Results obtained with tubocurarine are shown in table II. Tubocurarine did not induce significant contractures in the rat diaphragm, even at a concentration of 50 mmol litre"
1 . Contractures induced by suxamethonium in the presence of halothane were antagonized by tubocurarine (table II) . However, contractures induced by halothane in the presence of suxamethonium were not antagonized by tubocurarine (table III) . Dantrolene antagonized the contractures induced by either suxamethonium or halothane (tables II and III, respectively).
Two PLA, inhibitors, spermine and indomethacin, antagonized the interaction response to either suxamethonium (table II) or halothane  (table III) . A third PLA 2 inhibitor, quinacrine, did not antagonize suxamethonium-induced contractures in preparations pre-exposed to halothane (table IV) . In addition, quinacrine did not antagonize halothane-induced contractures in TABLE I. Interaction between halothane and suxamethonium on contractures induced in the rat diaphragm. Suxamethonium and halothane were added within 5 mm of each other. The values represent the maximum contracture within 5 min of addition of the second agent. Significant differences (P < 0.05) when compared with: *1% halothane alone; tSuxamethonium SO mmol litre-' alone; XSuxamethonium 1 mmol litre'' followed by 1% halothane; ^Suxamethonium 10 mmol litre-' followed by 1% halothane; Suxamethonium 50 mmol litre-' followed by 1% halothane; ** 3% halothane alone preparations pre-exposed to suxamethonium (table IV) . The response to 1% halothane following the addition of quinacrine to the bath Suxamethonium and halothane act synergistically (no suxamethonium present) was much greater to induce contractures in directly stimulated than in the absence of quinacrine (table IV) . muscle strips isolated from the rat diaphragm. Quinacrine also enhanced suxamethonium-This interaction is similar to that observed induced contractures in the absence of halothane using preparations isolated from biopsies of in the bath (table IV) . human skeletal muscle Rosenberg, 1985, 1986) . This interaction between halothane and suxamethonium does not appear to be simply additive, as the order in which the drugs were added determined the degree of response to the second agent. For example, the response to suxamethonium 50 mmol litre" 1 was not significantly increased in preparations pre-incubated with halothane when the halothane concentration was increased from 1 to 3 %. In contrast, the response to halothane in preparations pre-exposed to suxamethonium 50 mmol litre" 1 was increased when the concentration of halothane was increased from 1 to 3%. Also, there was essentially no response to suxamethonium 10 mmol litre" 1 in the presence of 1 % halothane. When the order in which the agents were added to the bath was reversed, 1 % halothane-induced contractures were increased significantly in the presence of suxamethonium 10 mmol litre"
1 . Thus, separate mechanisms may be involved in the response to each of the agents. Further evidence for separate mechanisms in halothane-and suxamethoniuminduced contractures was the observation that tubocurarine antagonized suxamethonium-induced contractures, but not those induced by halothane. These results are in agreement with the clinical situation in regard to MH: that is, tubocurarine can prevent suxamethonium-induced MH, but not halothane-induced MH (Harrison, 1971; Hall, Lucke and Lister, 1976) . These results may not be mediated at the endplate, as such high concentrations of suxamethonium and tubocurarine are required, respectively, to induce or antagonize contractures.
The results of the present study, using indomethacin and spermine, suggest that PLA 2 activity may be involved in halothane and suxamethonium-induced contractures in the rat diaphragm. The results obtained with quinacrine on the diaphragm preparation are more complex. Studies using human muscle have demonstrated that quinacrine can block halothane and suxamethonium-induced contractures (Fletcher and Rosenberg, 1986) . A recent report suggests that the increased specific activity in pigs susceptible to the porcine stress syndrome may result from a greater concentration of calmodulin (Cheah, 1984) , which would stimulate calmodulindependent PL A,. Although we do not understand the difference in response between rat and human preparations, one possible explanation is that PLAj activity of the rat diaphragm may not be calmodulin-dependent. Alternatively, an action of quinacrine other than the inhibition of PLA^ may account for the potentiation of the contractures induced by halothane and suxamethonium. Regardless of the reason for this discrepancy, the difference between human and rat preparations in the action of quinacrine can be used to understand better the role of lipolysis in the induction of contractures. Although PLA 2 activity is presumed to be the source of fatty acids, it is premature to eliminate other lipolytic enzymes including PLA 13 triglyceride lipase, diglyceride lipase, and so on.
Dantrolene is known to block Ca t+ release from the sarcoplasmic reticulum (Martonosi, 1984) . In view of the present study, dantrolene could be a potent PLAj inhibitor. The inhibition of PLA S activity could be either direct or indirect. An example of an indirect mechanism would be the blocking of Ca i+ availability to the (Independent PLAj enzyme. Alternatively, dantrolene may physiologically antagonize the effects of the unsaturated fatty acids on Ca 2+ regulation.
In conclusion, muscle strips isolated from the rat diaphragm are useful in investigations of drug-induced contractures. The fibre strips are thin and are mostly uncut-highly desirable features when compared with the human and pig fibre bundles used frequently in such studies. The interaction between halothane and suxamethonium in the present studies appears similar to that observed using human skeletal muscle, except for the interactions of halothane and suxamethonium with quinacrine. In addition, the present study demonstrates that suxamethonium and halothane induce contractures through different mechanisms. These studies support a role for fatty acids in contractures synergistically induced by halothane and suxamethonium.
